SRC and cancer: On the other hand, SRC displayed a potential inhibitory effect on the cell cycle (16%), hormone AR (16%), hormone ER (hormone estrogen receptor; 16%) and apoptosis (12%) pathways in pan-cancer (Figure 3a).